HTBC TechBio. Session 2
By Leigh Brody
Introducing the HTBC TechBio
The HTBC debuts the TechBio Chapter to put the intersection of biology and technology in the spotlight. Led by Leigh Brody, Investment Manager AlbionVC, the sessions welcome founders, operators, and investors to gather over breakfast, the most important meal of the day, for engaging discussions and networking opportunities within the dynamic field of techbio.
The format is a facilitated roundtable discussions with guest speakers or experts, encouraging all attendees to bring questions, insights, and ideas to the breakfast table.
HTBC TechBio sessions will explore new frontiers converging biology and technology. This intersection promises a new playbook for tackling complex challenges across biological understanding, AI drug discovery, digital health and clinical research. Join us as discuss the current state of the field, key challenges and drivers, and future prospects.
The HTBC TechBio breakfasts will occur quarterly, so if you can’t make this one be sure to keep in touch for future events.
If you’re interested in joining (limited spaces), sign up by clicking below
Related news
UCL spinout Echopoint Medical secures £4.2m Series A
